These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32600694)

  • 41. Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study.
    Alfonso F; Cuesta J; Pérez-Vizcayno MJ; García Del Blanco B; Rumoroso JR; Bosa F; Pérez de Prado A; Masotti M; Moreno R; Cequier A; Gutiérrez H; García Touchard A; López-Mínguez JR; Zueco J; Martí V; Velázquez M; Morís C; Bastante T; García-Guimaraes M; Rivero F; Fernández C;
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1841-1851. PubMed ID: 28866036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simvastatin decreases stent-induced in-stent restenosis rate via downregulating the expression of PCNA and upregulating that of p27kip1.
    Gao C; Xu W; Xiao W; Yu J; Li M
    J Interv Cardiol; 2013 Aug; 26(4):384-91. PubMed ID: 23941653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eupatolide inhibits PDGF-induced proliferation and migration of aortic smooth muscle cells through ROS-dependent heme oxygenase-1 induction.
    Kim N; Hwangbo C; Lee S; Lee JH
    Phytother Res; 2013 Nov; 27(11):1700-7. PubMed ID: 23297002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
    Kajiya T; Yamaguchi H; Takaoka J; Fukunaga K; Arima R; Miyamura A; Ninomiya T; Atsuchi N; Atsuchi Y; Terashima M; Kaneda H; Ohishi M
    Singapore Med J; 2019 Jan; 60(1):48-51. PubMed ID: 29632955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effects of drug-eluting coronary stents].
    Keltai M
    Orv Hetil; 2007 Mar; 148(10):443-50. PubMed ID: 17350910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cu-bearing steel reduce inflammation after stent implantation.
    Li J; Ren L; Zhang S; Ren G; Yang K
    J Mater Sci Mater Med; 2015 Feb; 26(2):114. PubMed ID: 25665852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory effects of OD 78 [3-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl ester] on the proliferation and migration of TNF-α-induced rat aortic smooth muscle cells.
    Lim Y; Tudev M; Park ES; Kim WS; Lim IH; Lee MY; Lee H; Jung JK; Hong JT; Yoo HS; Lee MK; Pyo MY; Yun YP
    Arch Pharm Res; 2011 Jul; 34(7):1191-9. PubMed ID: 21811927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings.
    Hu T; Lin S; Du R; Fu M; Rao Q; Yin T; Huang Y; Wang G
    Biomater Sci; 2017 Aug; 5(9):1845-1857. PubMed ID: 28676873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory effects of scoparone from chestnut inner shell on platelet-derived growth factor-BB-induced vascular smooth muscle cell migration and vascular neointima hyperplasia.
    Jung SH; Lee GB; Ryu Y; Cui L; Lee HM; Kim J; Kim B; Won KJ
    J Sci Food Agric; 2019 Jul; 99(9):4397-4406. PubMed ID: 30861122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of granulocyte-colony stimulating factor in bare stent and sirolimus-eluting stent in pigs following myocardial infarction.
    Lim SY; Kim YS; Ahn Y; Jeong MH; Rok LS; Kim JH; Kim KH; Park HW; Kim W; Cho JG; Park JC; Kang PM; Schwartz RS; Kang JC
    Int J Cardiol; 2007 Jun; 118(3):304-11. PubMed ID: 17052793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Innovative erythrocyte-based carriers for gene delivery in porcine vascular smooth muscle cells: basis for local therapy to prevent restenosis.
    Lande C; Cecchettini A; Tedeschi L; Taranta M; Naldi I; Citti L; Trivella MG; Grimaldi S; Cinti C
    Cardiovasc Hematol Disord Drug Targets; 2012 Sep; 12(1):68-75. PubMed ID: 22746344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects.
    Li JJ; Li J; Nan JL; Li Z; Zhen X; Mu CW; Dai J; Zhang CY
    Med Hypotheses; 2007; 69(5):1004-9. PubMed ID: 17499449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
    Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
    Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclic strain amplitude dictates the growth response of vascular smooth muscle cells in vitro: role in in-stent restenosis and inhibition with a sirolimus drug-eluting stent.
    Colombo A; Guha S; Mackle JN; Cahill PA; Lally C
    Biomech Model Mechanobiol; 2013 Aug; 12(4):671-83. PubMed ID: 22961302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.